Tag: Wesana Health - Page 3 - Psychedelic Alpha

Read more about the article Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board

Renowned Psychedelic Researcher, James Fadiman, PhD, Joins Wesana Health Scientific Advisory Board

Post published:May 27, 2021
Post category:Press Release

Read more about the article Wesana Health Expands Research Leadership Team with Mark Wingertzahn, PhD as Chief Scientific Officer

Wesana Health Expands Research Leadership Team with Mark Wingertzahn, PhD as Chief Scientific Officer

Post published:May 21, 2021
Post category:Press Release

Read more about the article The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain InjuryThe World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain Injury

The World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain InjuryThe World Boxing Council and Wesana Health Announce Multi-Year Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain Injury

Post published:May 13, 2021
Post category:Press Release

Read more about the article Wesana Health Commences Trading on the CSE

Wesana Health Commences Trading on the CSE

Post published:May 10, 2021
Post category:Press Release

Read more about the article Wesana Health Announces Closing of C$16.1 Million Oversubscribed Private Placement

Wesana Health Announces Closing of C$16.1 Million Oversubscribed Private Placement

Post published:March 31, 2021
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.